# LEAH Labs

Source: https://onco.cc/companies/leah-labs/  
OnCo record `leah-labs` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

LEAH Labs makes CAR-T cell therapy for dogs with lymphoma, using virus-free gene editing to bring the cost of a dose down to hundreds of dollars.

## Summary

LEAH Labs (LifEngine Animal Health Laboratories) is developing CAR-T cell therapy for dogs with B-cell lymphoma, the naturally occurring counterpart of human non-Hodgkin lymphoma, using a non-viral gene-editing approach that the company says brings manufacturing cost to roughly $500 per dose. Its YC profile reports remissions in dogs with late-stage lymphoma. Veterinary cell therapies are regulated by the USDA rather than the FDA, which the company uses to iterate faster; the stated long-term aim is to carry the platform into human oncology.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: veterinary; comparative-oncology
- HQ: Minneapolis, MN
- Type: cell-therapy
- Website: https://www.leahlabs.com

## Sources

- Y Combinator profile: https://www.ycombinator.com/companies/leah-labs
- Official website: https://www.leahlabs.com

## Connected records

- cancers: [Diffuse large B-cell lymphoma](https://onco.cc/cancers/dlbcl/)
- fronts: [Cell Therapy](https://onco.cc/fronts/cell-therapy/)
- technologies: [CAR-T cell therapy](https://onco.cc/technologies/car-t/)
- targets: [CD20](https://onco.cc/targets/cd20/)
- companies: [Y Combinator](https://onco.cc/companies/y-combinator/)

---
JSON: https://onco.cc/api/v1/entities/leah-labs.json